|
References for Promoting Youthful Function
By Richard Walker, PhD, RPh
Vol. 3, Issue 7
Pp. 49-54
1. Rudman D, Feller AG, Nagraj HS et al. Effects of human growth hormone in men over 60 years old. New Eng J Med 1990; 323 (1):1-6
2. Bertherat J, Timsit J, Bleut-Pajot MT, Mercadier JJ, Goiurdji D, Kordon C, Epelbaum J. Chronic growth hormone hypersecretion induces reciprocal and reversible changes in mRNA levels from hypothalamic GH releasing hormone and somatostatin neurons. J Clin Invest. 1993 April; 91(4): 1783-1791
3. Horikawa R, Hellmann P, Cella SG, Torsello A, Day RN, Muller E, Thorner M. Growth hormone releasing factor regulates expression of its own receptor. Endocrinology 1996; 137(6):2642-2645.
4. Blackard WL, Heidingsfelder SA: Adrenergic receptor control mechanism for growth hormone secretion. Journal of Clinical Investigation. 1968; 47 1407-1414
5. Wong DF, Young D,Wilson PD, Meltzer CC, Gjedde A. Quantification of neuroreceptors in the living human brain: III. D2-Like dopamine receptors: Theory, validation, and changes during normal aging. Journal of Cerebral Blood Flow & Metabolism. 1997; 17, 316-330
6. Mohandumar PS, Thyagarajan S, Quadri SK. Correlations of catecholamine release in the medial preoptic area with proestrous surges of luteinizing hormone and prolactin: Effects of aging. Endocrinology, 1994; 135: 119-126.
7. Simpkins JW, Mueller GP, Huang HH, Meites J. Evidence for depressed catecholamine and enhanced serotonin metabolism in aging male rats: Possible relation to gonadotropin secretion. Endocrinology. 1977;100:1672-1678.
8. Sonntag WE, Forman LJ, Miki N, Trapp, PE. L-dopa restores amplitude of growth hormone pulses in old male rats to that observed in young male. Neuroendocrinology. 1982; 34:163-168
9. Sonntag WE, Onder G, Pahor M. Catecholamine precursors restore the anabolic effects of growth hormone upon the body. J. Gerontol. 1985; 40:689-694.
10. Cotzias GC, Miller ST, Nicholson AR, Maston WH, Tang, LC. Prolongation of life span in mice adapted to large amounts of L-Dopa. Proc. Nat. Acad. Sci. USA, 1974; 71:2466-2469
11. Ruehl WW. MAO inhibitors improve neuroendocrine function and extend life. Life Sciences 1997; 61(11):1037-1044.
12. Walker R F, Weideman, CA, Wheeldon, EB. Reduced disease in aged rats treated chronically with ibopamine, a catecholaminergic drug. Neurobiol. Aging. 1988; 9:291-301.
|